Home > Boards > US Listed > Biotechs > Sorrento Therapeutics, Inc. (SRNE)

Bleach should never be injected or consumed by

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Alyssa Member Profile
 
Followed By 115
Posts 9,895
Boards Moderated 0
Alias Born 07/17/05
160x600 placeholder
Current Report Filing (8-k) Edgar (US Regulatory) - 9/17/2020 6:04:36 AM
Sorrento Receives US FDA Clearance to Proceed With Phase 1 Clinical Trial of STI-1499 (COVI-GUARD) Neutralizing Antibody in C... GlobeNewswire Inc. - 9/16/2020 9:30:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/14/2020 6:04:19 AM
Sorrento Secures Exclusive License From Mayo Clinic for Antibody-Drug-Nanoparticle Albumin-Bound Immune Complex (ADNIC) Platf... GlobeNewswire Inc. - 9/14/2020 6:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/2/2020 9:10:45 AM
Sorrento Announces the Closing of Its Acquisition of SmartPharm to Build Next Generation G-MAB-Encoded Plasmid DNA For Cost-E... GlobeNewswire Inc. - 9/2/2020 9:00:10 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 8/21/2020 5:27:30 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 8/21/2020 4:49:01 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/20/2020 4:56:30 PM
Sorrento Enters Into Merger Agreement to Acquire SmartPharm and Develop Pipeline of Gene-Encoded Therapeutic Antibodies, Star... GlobeNewswire Inc. - 8/20/2020 4:05:10 PM
Sorrento Announces FDA IND Filing Today for COVI-GUARD Neutralizing and High Potency Antibody Against SARS-CoV-2 GlobeNewswire Inc. - 8/19/2020 9:00:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/18/2020 4:48:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 8/14/2020 7:45:15 PM
Sorrento to Take Action Against Hindenburg Research for Statements Believed Intended to Manipulate Stock Price GlobeNewswire Inc. - 8/12/2020 7:51:28 PM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 8/10/2020 6:29:08 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/10/2020 6:28:13 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/4/2020 4:35:24 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/29/2020 9:02:27 AM
Sorrento Announces License From Columbia University For Rapid On-Site Detection Test For SARS-CoV-2 Virus In Saliva PR Newswire (US) - 7/29/2020 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/24/2020 9:01:06 AM
Sorrento Enters Into Letter Of Intent To Acquire SmartPharm And Develop Pipeline Of Gene-Encoded Therapeutic Antibodies, Star... PR Newswire (US) - 7/24/2020 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/20/2020 9:01:02 AM
FDA clears Abivertinib for Phase 2 safety and efficacy study in hospitalized patients with moderate to severe COVID-19 PR Newswire (US) - 7/20/2020 9:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/17/2020 4:41:23 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/1/2020 4:39:29 PM
Alyssa   Monday, 05/18/20 08:05:51 AM
Re: agribusiness72 post# 2662
Post # of 6182 
Bleach should never be injected or consumed by any human. The stock has been undervalued for a very long time WITHOUT this latest news, and if you are insinuating dilution, that’s not their style.

And the company has lots more going for it than its Covid 19 involvement.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences